Treatment of refractory spondyloarthropathies;TRAITEMENT DES SPONDYLARTHROPATHIES REFRACTAIRES

Presse Medicale

Volumn 27, Issue 4, 1998, Pages 175-180

  Dubost, J J ^a   Soubrier, M ^a   Sauvezie, B ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CYCLOPHOSPHAMIDE; HLA B27 ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; ANTIINFLAMMATORY AGENT;

ANKYLOSING SPONDYLITIS; HUMAN; REACTIVE ARTHRITIS; REVIEW; SPONDYLOARTHROPATHY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; PATHOPHYSIOLOGY; RECURRENT DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; METHOTREXATE; METHYLPREDNISOLONE; RECURRENCE; SPONDYLITIS, ANKYLOSING; SULFASALAZINE;

EID: 0032583841     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Amor B, Dougados M, Mijiywa M. Critères de classification des spondylarthropathies. Rev Rhum 1990 ; 57:85-9.
2. Amor B, Dougados M, Khan MA. Management of refractory ankylosing spondylitis and related spondyloarthropathies. Rheum Dis Clin North Am 1995 ; 21 : 117-28.
3. Chary-Val Ckenaere I, Jaulhac B, Monteil H, Pourel J. Le diagnostic de l'arthrite de Lyme. Difficultés et perspectives. Rev Rhum 1995 ; 62:283-92.
4. Kinigadner U, Mur E, Most J, Frank R, Stanek. Borrelia infection as a possible cause of HLA-B27 negative sacroiliitis. J Rheumatol 1991 ; 18:484-5.
5. Van Offel JF, De Clerck LS, Francx LM, De Jonge MJ, Stevens WJ. A patient with ochronotic arthropathy and spondylopathy : a difficult differential diagnosis with spondylitis ankylosans. Clin Exp Rheumatol 1995 ; 13:259-61.
6. Maugars Y, Mathis C, Vilon P, Prost A. Corticosteroid injection of the sacroiliac joint in patients with seronegative spondylarthropathy. Arthritis Rheum 1992 ; 35:564-8.
7. Maugars Y, Mathis C, Berthelot JM, Chalier C, Prost A. Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies : a double-blind study. Br J Rheumatol 1996 ; 35:765-70.
8. Chazerain P, Strauss C, Perrot S, Ziza JM. Efficacité de la corticothérapie intra-articulaire dans les sacro-iliites rhumatismales (Abstract). Rev Rhum 1992 ; 59:620.
9. Braun J, Bollow M, Seyrekbasan F et al. Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis : clinical outcome and followup by dynamic magnetic resonance imaging. J Rheumatol 1996 ; 23:659-64.
10. Bollow M, Braun J, Taupitz M et al. CT-guided intra-articular corticosteroid injection into the sacroiliac joints in patients with spondyloarthropathy : indication and follow-up with contrast-enhenced MRI. J Comput Assist Tomogr 1996 ; 20:512-21.
11. Dougados M, Berenbaum F, Maetzel A, Amor B, Prévention des épisodes d'uvéite antérieure aiguë des spondylarthropathies par la salazosulfapyridine. Rev Rhum 1993 ; 60:81-3.
12. Hedner LP, Bynke G. Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Ophthalmol 1985 ; 100:618-19.
13. Zierhut M, Pleyer U, Waetjen R, Thiel HJ, Weidle EG. Chronic anterior uveitis treated with bromocriptine In: Ocular Immunology Today. Proceeding 5th International symposium on the Immunology and Immunopathology of the eye, Tokyo, March 13-15, 1990. Usui M, Ohno S, Aoki K, eds. Excerpta Medica, Amsterdam 1990 463-6.
14. Palestine AG, Nussenblatt RB. The effect of bromocriptine on anterior uveitis. Am J Ophthalmol 1988 ; 106:488-9.
15. Mintz G, Ennquez RD, Mercado U, Robles EJ, Jimenez FJ, Gutierrez G. Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis. Arthritis Rheum 1981 ; 24:734-6.
16. Richter MB, Woo P, Panayi GS, Trull A, Unger A, Shepherd P. The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis. Clin Exp Immunol 1983 ; 53:51-9.
17. Ejstrup L, Peters DN. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Dan Med Bull 1985 ; 32:231-3.
18. Yoshida S, Motai Y, Hattori H, Yoshida H, Torikai K. A case of HLA-B27 negative ankylosing spondylitis treated with methylprednisolone pulse therapy. J Rheumatol 1993 ; 20:1805-6.
19. Peters ND, Ejstrup L. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scand J Rheumatol 1992 ; 21:134-8.
20. Ferraz MB, Tugwell P, Goldsmith CH, Atra E. Meta-analysis of sulfasalazine in ankylosing spondylitis. J Rheumatol 1990 ; 17:1482-6.
21. Clegg DO, Reda DJ, Weisman MH et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996 ; 39:2004-12.
22. Dougados M, Maetzel A, Mijiyawa M, Amor B. Evaluation of sulphasalazine in the treatment of spondylarthropathies. Ann Rheum Dis 1992 ; 51:955-8.
23. Dougados M, Van Der Linden S, Leirisalo-Repo M et al. Sulfasalazine in the treatment of spondylarthropathy. A randomized multicenter, double-bind placebo-controlled study. Arthritis Rheum 1995 ; 38:618-27.
24. Clegg Do, Reda DJ., Weisman MH et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996 ; 39:2021-7.
25. Thomson GTD, McKibbon C, Inman RD. Mesalamine therapy in Reiter's syndrome. J Rheumatol 1994 ; 21:570-72.
26. Taggart A, Gardiner P, McEvoy F, Hopkin S R, Bird H. Which is the active moiety of sulfasalazine in ankylosing spondylitis ? A randomized, controlled study. Arthritis Rheum 1996 ; 39:1400-5.
27. Sutherland LR, May CR, Shaffer EA. Sulfasalazine revisited : a meta-analysis of 5aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993 ; 118:540-9.
28. Handler RP. Favorable results using methotrexate in the treatment of patients with ankylosing spondylitis. Arthritis Rheum 1989 ; 32:234.
29. Bosi Ferraz M, Carrico Da Silva HC, Atra E. Low dose methotrexate with leucovorin rescue in AS. J Rheumatol 1991 ; 18:146-7.
30. Yamane K, Saito L, Natsuda H et al. Ankylosing spondylitis successfully treated with methotrexate. Intern Med 1993 ; 32:53-6.
31. Sampaio-Barros PD, Costallat LTL, Fernandes SRM, Samara AM. The use of methotrexate in the treatment of ankylosing spondylitis : pilot study. Rev Exp Rheumatol 1993 ; 20(supppl. 1):485.
32. Creemers MCW, Franssen MJA, Van de Putte LBA, Gribnau FWJ, Van Riel PLCM. Methotrexate in severe ankylosing spondylitis : an open study. J Rheumatol 1995 ; 22:1104-7.
33. Osendorf B, Specker C, Schneider M. Ankylosing spondylitis clinical and serological response to methotrexate therapy compared with rheumatoid arthritis.(Abstr). Arthritis Rheum 1995 ; 38(suppl):S203.
34. Toussirot E, Wendling D. L'utilisation du méthotrexate dans les spondylarthropathies. Revue de la littérature. Rev Med Interne 1996 ; 17:333-9.
35. Creemers MCW, Van Riel PLCM., Franssen MJAM., Van de Putte LBA, Gribnau FWS. Second-line treatment in seronegative spondylarthropathies. Semin Arthritis Rheum 1994 ; 24:71-81.
36. Steven MM, Morrison M, Sturrock RD. Penicillamine in ankylosing spondylitis : a double blind placebo controlled trial. J Rheumatol 1985 ; 12:735-7.
37. Calin A. A placebo controlled, crossover study of azathioprine in Reiter's syndrome. Ann Rheum Dis 1986 ; 45:653-5.
38. Sadowska-Woblewska M, Garwolinska H, Maczinska-Rusinak B. A trial of cyclophosphamide in ankylosing spondylitis with involvement of peripheral joints and high disease activity. Scand J Rheum 1986 ; 15:259-64.
39. Alberts AS, Brighton SW, Kempff P et al. Samarium-153-EDTMP for palliation of ankylosing spondylitis, Paget's disease and rheumatoid arthritis. J Nucl Med 1995 ; 36:1417-20.
40. Maksymowych WP, Maguire C, Hoskinson M, Russell AS. An open study of intravenous pamidromate in the treatment of refractory ankylosing spondylitis. Abstr. Arthritis Rheum 1996 ; 39:S256.
41. Weber G, Frey H. Results of treatment of psoriatic arthritis with bromocriptine. Z Heutkr 1986 ; 61:1456-66.
42. Buskila D, Sukenik S, Holoberg G, Horowitz J. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia. J Rheumatol 1991 ; 18:611-12.
43. Eulry F, Mayaudon H, Bauduceau B et al. Prolactinémie sous protiréline (TRH) dans les spondylarthropathies. Ann Med Interne 1996 ; 147:15-19.
44. Bravo G, Zazuet B, Lavalle C. An acute remission of Reiter's syndrome in male patients treated with bromocriptine. J Rheumatol 1922 ; 19:747-50.
45. Antoine JF, Marce S, Shaeverbeke T, Vernhes JP, Dehais J. Echec de la bromocriptine (BRC) dans deux cas d'arthrites réactionnelles (AR) (Abstr.). Rev Rhum 1993 ; 60:662.
46. Bravo G, Zazueta B, Felix A, Irigoven L. Juvenile ankylosing spondylitis (JAS) : direct relationship between hyper -prolactinemia and interleukin-6 (IL-6). Abstr. Arthritis Rheum 1994 ; 37(suppl):S 428.
47. Hughes RA, Keat AC. Reiter's syndrome and reactive arthritis : a current view. Semin Arthritis Rheum 1994 ; 24:190-210.
48. Garcia CO, Paira S, Burgos R et al. Detection of Salmonella DNA in synovial membrane and synovial fluid from latin american patients with reactive arthritis using the polymerase chain reaction. Abstr. Arthritis Rheum 1996 ; 39(supl.):S185.
49. Nikkari S, Möttönen T, Saario R et al. Demonstration of salmonella DNA in the synovial fluid in reactive arthritis. Abstr. Arthritis Rheum 1996 ; 39(suppl.):S185.
50. Bardin T, Enel C, Lathrop M. Treatment by tetracyclin or erythromycine of urethritides allows significant prevention of post-venereal arthritic flares in Reiter's syndrome patients (Abstr.). Arthritis Rheum 1990 ; 33:S26.
51. Zhang Y, Gripenberg-Lerche C, Soderstrom KO, Toivanen A, Toivanen P. Antibiotic prophylaxis and treatment of reactive arthritis. Lesson from an animal model. Arthritis Rheum 1996 ; 39:1238-43.
52. Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H. Double-blind placebo controlled study of three month treatment with lymecycline in reactive arthritis with special reference to chlamydia arthritis. Arthritis Rheum 1991 ; 34:6-14.
53. Toivanen A, Yli-Kerttula T, Luukkainen R, Merlahti-Palo R, Granfors K, Seppala J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993 ; 11:301-7.
54. Kingsley G, Sierper J. Third international workshop on reactive arthritis - An overview. Ann Rheum Dis 1996 ; 55:564-70.
55. Brantus JF, Meunier PJ. Manifestations rhumatologiques associées à l'infection par le virus de l'immunodéficience humaine (V.I.H.). Rev Rhum 1992 ; 59:428-35.
56. Yousseff PP, Bertouch JV, Jones PD. Successful treatment of human immunodeficiency virus-associated Reiter's syndrome with sulfasalazine. Arthritis Rheum 1992 ; 35:723-4.
57. Belz J, Breneman DI, Nordlund JO, Solinger A. Successful treatment of a patient with Reiters syndrome and acquired immunodeficiency syndrome using etretinate. J Am Acad Dermatol 1989 ; 20:898-903.
58. Louthrenoo W. Successful treatment of severe Reiter's syndrome associated with human immunodeficiency virus infection with etretinate. Report of 2 cases. J Rheumatol 1993 ; 20:1243-6.
59. Shapiro D, Masci JR. Treatment of HIV associated psoriatic arthritis with oral gold. J Rheumatol 1996 ; 23:1818-20.
60. Ornstein MH, Sperber K. The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis Rheum 1996 ; 39:157-61.
61. Allen B.R. Use of cyclosporin for psoriasis in HIV-positive patient. Lancet 1992 ; 339: 686.
62. Winchester R, Bernstein DH, Fischer HD, Enlow R, Solomon G. The co-occurence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987;106:19-26.
63. Maurer TA, Zackeim HS, Tuffanelli L, Berger TG. The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol 1994 ; 31:372-5.
64. Itescu S. Rheumatic aspects of acquired immunodeficiency syndrome. Current Opin Rheumatol 1996 ; 8: 346-53.